These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7117464)

  • 21. Effects of low concentrations of 4-aminopyridine on CA1 pyramidal cells of the hippocampus.
    Perreault P; Avoli M
    J Neurophysiol; 1989 May; 61(5):953-70. PubMed ID: 2566657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that protein kinase M does not maintain long-term potentiation.
    Denny JB; Polan-Curtain J; Rodriguez S; Wayner MJ; Armstrong DL
    Brain Res; 1990 Nov; 534(1-2):201-8. PubMed ID: 2073582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of excitatory amino acid receptors in synaptic transmission in area CA1 of rat hippocampus.
    Davies SN; Collingridge GL
    Proc R Soc Lond B Biol Sci; 1989 May; 236(1285):373-84. PubMed ID: 2567518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular correlates of morphine excitation in the hippocampal slice preparation.
    Robinson JH; Deadwyler SA
    Brain Res; 1981 Nov; 224(2):375-87. PubMed ID: 7284847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Amino-3-phosphonopropionate blocks the induction and maintenance of long-term potentiation in rat hippocampal slices.
    Izumi Y; Clifford DB; Zorumski CF
    Neurosci Lett; 1991 Jan; 122(2):187-90. PubMed ID: 1674119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of metabotropic glutamate receptors protects rat CA1 neurons from hypoxic injury.
    Opitz T; Reymann KG
    Neuroreport; 1991 Aug; 2(8):455-7. PubMed ID: 1680488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMDA receptors at excitatory synapses in the hippocampus: test of a theory of magnesium block.
    Bekkers JM; Stevens CF
    Neurosci Lett; 1993 Jun; 156(1-2):73-7. PubMed ID: 8414193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The amnesic substance 2-deoxy-D-galactose suppresses the maintenance of hippocampal LTP.
    Krug M; Jork R; Reymann K; Wagner M; Matthies H
    Brain Res; 1991 Feb; 540(1-2):237-42. PubMed ID: 2054616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postsynaptic potentials mediated by excitatory and inhibitory amino acids in interneurons of stratum pyramidale of the CA1 region of rat hippocampal slices in vitro.
    Lacaille JC
    J Neurophysiol; 1991 Nov; 66(5):1441-54. PubMed ID: 1684988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin(14) and -(28) but not somatostatin(1-12) hyperpolarize CA1 pyramidal neurons in vitro.
    Watson TW; Pittman QJ
    Brain Res; 1988 May; 448(1):40-5. PubMed ID: 2898967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of hippocampal long-term potentiation by alpha-tocopherol.
    Xie Z; Sastry BR
    Brain Res; 1993 Feb; 604(1-2):173-9. PubMed ID: 8457845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphenylhydantoin protects against hypoxia-induced impairment of hippocampal synaptic transmission.
    Stanton PK; Moskal JR
    Brain Res; 1991 Apr; 546(2):351-4. PubMed ID: 1648990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential blockade of hippocampal excitatory synaptic responses by an analogue of aspartate.
    Lanthorn TH
    Brain Res; 1984 Aug; 308(2):377-9. PubMed ID: 6478215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses in the CA1 region of the rat hippocampus to a noxious stimulus.
    Khanna S; Sinclair JG
    Exp Neurol; 1992 Jul; 117(1):28-35. PubMed ID: 1618285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of trifluoperazine on synaptically evoked potentials and membrane properties of CA1 pyramidal neurons of rat hippocampus in situ and in vitro.
    Agopyan N; Krnjević K
    Synapse; 1993 Jan; 13(1):10-9. PubMed ID: 7678946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin hyperpolarizes hippocampal pyramidal cells in vitro.
    Pittman QJ; Siggins GR
    Brain Res; 1981 Sep; 221(2):402-8. PubMed ID: 6116516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vincamine: a psychogeriatric agent blocking synaptic potentiation in hippocampus.
    Olpe HR; Barrionuevo G; Lynch G
    Life Sci; 1982 Nov; 31(18):1947-53. PubMed ID: 7176804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro.
    Lupica CR; Proctor WR; Dunwiddie TV
    Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The excitatory response of in vitro hippocampal pyramidal cells to normorphine and methionine-enkephalin may be mediated by different receptor populations.
    French ED; Zieglgänsberger W
    Exp Brain Res; 1982; 48(2):238-44. PubMed ID: 6293862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Region-specific age effects on AMPA sensitivity: electrophysiological evidence for loss of synaptic contacts in hippocampal field CA1.
    Barnes CA; Rao G; Foster TC; McNaughton BL
    Hippocampus; 1992 Oct; 2(4):457-68. PubMed ID: 1284976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.